Naloxone nasal spray, sold under the brand name Narcan, is shown in 2016. Emergent Biosolutions will pay $735 million in cash and stock to acquire Adapt Pharma, the Dublin, Ireland-based maker of Narcan. (Photo by Terrence Antonio James/Chicago Tribune/TNS/Sipa USA)

• Contributor: Sipa US / Alamy Stock Photo
• Image ID: 2EWRME3
• File size: 17.2 MB (484.9 KB Compressed download)
• Releases: Model - no | Property - no
• Dimensions: 3000 x 2000 px | 25.4 x 16.9 cm | 10 x 6.7 inches | 300dpi
• Date taken: 16 September 2016
• Photographer: TNS

More information

This image could have imperfections as it’s either historical or reportage.

Search stock photos by tags

• 04002006
• 07003001
• business
• chemical
• chemistry
• drug
• fin
• hea
• hth
• krtbusiness
• krtchemical
• medicine
• pharmaceutical